Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin patch for provoked vestibulodynia
NCT02854670Phase 3Terminated
- Sponsor
- CHU de Besançon
- Start
- Jan 2016
- Primary completion
- Feb 2021
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capsaicin 8% patch in vestibulodynia, sponsored by CHU de Besançon. Started Jan 2016; status: terminated.
02
Drugs
capsaicin 8% patch
03
Conditions
vestibulodynia
Beyond the preview
Go deeper on NCT02854670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02854670.